CARBYLAN THERAPEUTICS INC Chart calendar Carbylan Therapeutics Inc
1.oHRdNzQN_5C87DjwuqgjSBFoM0csDfGr2289D_h90AQ.4zMeUHhIh__I32yX290OL1YvWA50P4Oa7w1Va7ArtzPMKxhQRE-xofG6dQ~2acc551c6658ecd7eedaaa8199c5343e
Upcoming events on Carbylan Therapeutics Inc
Past events on Carbylan Therapeutics Inc
| 06/06/2024 12:30 am | Jefferies Global Healthcare Conference |
| 31/05/2024 | EAACI Congress |
| 30/05/2024 | EAC Conference |
| 28/05/2024 10:20 pm | Stifels Genetic Medicines Forum |
| 10/04/2024 07:45 pm | Needham Healthcare Conference |
| 12/03/2024 06:50 pm | Leerink Partners Global Biopharma Conference |
| 11/03/2024 04:00 pm | Q3 2024 Earnings Release |
| 25/02/2024 08:15 pm | American Academy of Allergy, Asthma & Immunology Meeting |
| 24/02/2024 08:15 pm | American Academy of Allergy, Asthma & Immunology Meeting |
| 13/02/2024 07:00 pm | KONFIDENT Phase 3 Trial Results Call |
| 07/12/2023 05:00 pm | Q2 2024 Earnings Release |
| 16/11/2023 03:00 pm | Jefferies London Healthcare Conference |
| 15/11/2023 01:30 am | Stifel Healthcare Conference |
| 13/11/2023 01:50 am | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P092 |
| 13/11/2023 01:50 am | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P070 |
| 13/11/2023 01:35 am | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P069 |
| 12/11/2023 01:20 am | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P085 |
| 11/11/2023 06:45 am | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P059 |
| 11/11/2023 06:00 am | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P078 |
| 28/09/2023 01:40 am | Cantor Global Healthcare Conference |
Annual results
| Fiscal Period | April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16,1 17,2 -6.44% | 12,7 10,5 20.43% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -29,8 -25,9 -15.32% | -40,5 -46,0 11.97% | -57,9 -54,6 -6.12% | -96,6 -98,2 1.59% | -111 -107 -3.28% | -126 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,7 -29,6 30.09% | -29,2 -35,4 17.49% | -46,2 -43,6 -5.95% | -82,3 -84,4 2.44% | -92,9 -93,3 0.41% | -114 |
|
Net income Million USD | Released Forecast Spread | -20,8 -29,6 29.68% | -29,1 -35,1 16.98% | -46,2 -43,7 -5.94% | -82,3 -84,6 2.69% | -92,9 -92,7 -0.26% | -114 |
|
EPS USD | Released Forecast Spread | -1,38 -2,11 34.6% | -1,64 -1,94 15.35% | -2,42 -2,30 -5.22% | -3,36 -3,45 2.67% | -3,33 -3,44 3.25% | -3,04 |
| Announcement Date | 15/07/19 | 29/06/20 | 13/07/21 | 07/07/22 | 07/07/23 | - |
Quarterly results
| Fiscal Period | April | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,69 | 1,04 | 5,98 |
|
EBIT Million USD | Released Forecast Spread | -26,7 -25,3 -5.5% | -26,8 -28,4 5.49% | -26,3 -27,7 4.87% | -25,9 -27,7 6.69% | -26,9 -28,2 4.6% | -31,7 -28,2 -12.45% | -29,1 -31,2 6.73% | -29,7 -29,8 0.33% | -33,2 -32,0 -3.58% | -34,1 | -34,1 | -34,7 | -35,5 | -29,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,5 -23,5 4.56% | -24,1 -26,7 9.76% | -23,0 -24,2 4.77% | -22,3 -25,9 13.92% | -21,3 -26,2 18.84% | -26,3 -26,7 1.43% | -25,3 -29,0 12.83% | -27,7 -27,1 -1.99% | -29,0 -30,5 4.79% | -31,6 | -31,3 | -32,0 | -32,9 | -27,2 |
|
Net income Million USD | Released Forecast Spread | -22,5 -22,3 -0.96% | -24,1 -26,8 10.09% | -23,0 -24,2 4.77% | -22,3 -26,1 14.68% | -21,3 -26,3 18.99% | -26,3 -26,1 -0.94% | -25,3 -29,0 12.83% | -27,7 -27,1 -1.99% | -29,0 -30,4 4.43% | -32,1 | -31,4 | -31,8 | -32,5 | -28,7 |
|
EPS USD | Released Forecast Spread | -0,92 -0,90 -2.6% | -0,98 -1,09 9.82% | -0,94 -0,97 3.09% | -0,90 -1,05 14.29% | -0,75 -1,00 25% | -0,77 -0,87 11.29% | -0,74 -0,84 11.9% | -0,80 -0,78 -2.13% | -0,84 -0,79 -6.55% | -0,72 | -0,67 | -0,68 | -0,69 | -0,59 |
| Announcement Date | 10/03/22 | 07/07/22 | 08/09/22 | 08/12/22 | 09/03/23 | 07/07/23 | 07/09/23 | 07/12/23 | 11/03/24 | - | - | - | - | - |
| 11/07/2024 11:30 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 16/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 23/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 11:30 am | BIOGAIA AB: Q2 2024 Earnings Release |
| 24/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 10:30 am | UCB: Q2 2024 Earnings Release |
| 26/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Carbylan Therapeutics Inc
| 23/05/2024 03:13 pm | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 09:05 pm | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 14/05/2024 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
| 10/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 10/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 12:00 pm | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
| 09/05/2024 01:46 am | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
